Argentinian Study Proves High Efficacy of Sputnik V in Protecting People Over 60, RDIF Says

MOSCOW (Sputnik) – A study conducted by the health ministry of the city of Buenos Aires, Argentina, showed high efficacy of the Russian-made COVID-19 vaccine Sputnik V in protecting people aged 60 and older, the Russian Direct Investment Fund (RDIF) said on Monday.